23/08/2025
In this clinic we are providing botox only for cosmetic purposes.
We are NOT providing (yet) neurotoxins for neutologic purposes
For your information, Botulinum Toxin it is used in Neurology:
Therapeutic Applications & Mechanisms
1. Mechanism of Action
Botulinum toxin (BoNT) acts by:
Presynaptic inhibition at neuromuscular junctions → blocks acetylcholine (ACh) release
Cleaves SNARE proteins (SNAP-25, VAMP, syntaxin) → prevents vesicle fusion
Effects last 3-6 months (until nerve terminals regenerate)
2. FDA-Approved Neurological Uses
A. Chronic Migraine
Injection Sites: 31-39 sites across frontal, temporal, occipital, and cervical muscles
Dose: 155-195 units (Botox®) q12 weeks
Efficacy: ~50% reduction in headache days/month
B. Spasticity (Post-Stroke, CP, MS)
Targets: Gastrocnemius (foot drop), biceps (flexor spasticity), adductors
Dose: 50-400 units per muscle (individualized)
Combines with PT/OT for best outcomes
C. Dystonia
Cervical dystonia (torticollis): Sternocleidomastoid, splenius capitis
Blepharospasm: Orbicularis oculi
Writer’s cramp: Forearm flexors
D. Hyperhidrosis (Excessive Sweating)
Palmar/axillary: 50-100 units per area
Effect: Anhidrosis for 4-12 months
3. Off-Label but Evidence-Based Uses
Trigeminal Neuralgia (masseter/temporalis injections)
Neurogenic Detrusor Overactivity (bladder injections)
Tremor (refractory essential tremor, dystonic tremor)
Bruxism (masseter injections)
4. Practical Considerations
Peak Effect: 2-4 weeks post-injection
Adverse Effects:
Local weakness (e.g., ptosis in blepharospasm)
Dysphagia (if neck muscles injected)
Dry mouth (migraine protocol)
Contraindications:
Myasthenia gravis, ALS, Lambert-Eaton syndrome
Allergy to BoNT components
5. Future Directions
Newer Toxins: IncobotulinumtoxinA (longer duration)
Non-motor Applications: Depression (facial feedback hypothesis), neuropathic pain